TG THERAPEUTICS, INC. (TGTX) › Capital ExpendituresTG THERAPEUTICS, INC. (TGTX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $02012: $1.4K2013: $5.7K2014: $18.6K2015: $42.2K2016: $344.0K2017: $2.0K2018: $90.0K2019: $131.0K2020: $357.0K2021: $401.0K2022: $14.0K2023: $02024: $45.0K2025: $214.0K$214.0K2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$214.0K+375.6%2024$45.0K—2023$0-100.0%2022$14.0K-96.5%2021$401.0K+12.3%2020$357.0K+172.5%2019$131.0K+45.6%2018$90.0K+4400.0%2017$2.0K-99.4%2016$344.0K+714.8%2015$42.2K+127.3%2014$18.6K+226.9%2013$5.7K+306.1%2012$1.4K—2011$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share